ClinicalTrials.gg
RecruitingNCT05656001Updated Sep 16, 2026

Neuro- and Biofeedback in Nonsuicidal Self-injury

An interventional study of Real-time functional magnetic resonance imaging Neurofeedback and Real-time Biofeedback and Sham functional magnetic resonance imaging neurofeedback and sham biofeedback in Nonsuicidal Self Injury and Emotion Regulation, sponsored by Region Östergötland. Recruiting at 1 site in Sweden. Open to participants aged 15 Years to 19 Years. Per ClinicalTrials.gov, last updated 2026-09-16.

Sponsored by Region Östergötland · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 4 months after the study started (first participant enrolled Sep 2021, registered Jan 2022).
  • Started Sep 2021; still recruiting 5 years 2 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
15 Years to 19 Years
Sex
All
01

Study summary

Nonsuicidal self-injury (NSSI) is defined as the direct, deliberate destruction of one's own body tissue without suicidal intent, typically including behaviors such as cutting, burning, or hitting oneself. The risk of engaging in NSSI is particularly high during adolescence. NSSI is associated with impairments in emotion regulation and NSSI behavior serves as an attempt to regulate emotion. We propose to examine whether training adolescents with NSSI to self-regulate using emotion regulation skills to down-regulate hemodynamic activity of the salience network, involved in emotional processing. Moreover, we propose to examine whether limbic-prefrontal cortex connectivity can be increased following neurofeedback, thereby helping adolescents find an optimal way to emotionally regulate with the help of neurofeedback, instead of engaging in NSSI to regulate emotions. We also aim to examine effects of real-time biofeedback by investigating if adolescents can regulate their psychophysiological activity during emotional reactivity with biofeedback. Sixty participants with NSSI will be recruited and offered either real-time functional magnetic resonance imaging (rt-fMRI-NF) (n = 30) or real-time biofeedback (n = 30) training. Participants each each condition will then be randomized to either an active or a control condition (n = 15/group). Participants will take part in three runs of feedback training. Changes in emotional reactivity as measured with facial electromyography (EMG) before and after feedback training will be the proximal outcome measure together with changes of the blood oxygenation level dependent (BOLD) response during real-time fMRI-neurofeedback for the neurofeedback training. Proximal outcome measures for the biofeedback will include psychophysiological measures of emotional reactivity (facialEMG). More distal outcome measures for both neuro- and biofeedback will be measures of NSSI: frequency, methods and severity as well as self-report measures of difficulties with regulating emotions, emotional reactivity and psychiatric symptoms.

02

Conditions studied

  • Nonsuicidal Self Injury
  • Emotion Regulation

Keywords

  • nonsuicidal self-injury
  • emotion regulation
  • adolescents
  • neurofeedback
  • biofeedback
03

In context

Self-Injurious Behavior

303 studies on the registry are indexed under Self-Injurious Behavior; 105 are open to participants now.

This study's planned enrollment of 60 is below the median of 70 across 254 interventional studies indexed under Self-Injurious Behavior.

Browse Self-Injurious Behavior studies →

Lead sponsor

Region Östergötland is the lead sponsor of 29 studies on the registry; 8 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
15 Years to 19 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • ongoing contact at the child- and adolescent psychiatric clinics in both Linköping and Norrköping, Sweden
  • ongoing contact at the primary care facilities in Linköping and Norrköping (Ungdomshälsan, Råd, Stöd \& Hälsa)
  • NSSI, independent of psychiatric diagnosis
  • between 15 and 19 years of age
  • having engaged in five or more instances of NSSI during the last six months
  • the patient is cognitively capable to decide for him- or herself

Exclusion criteria

Exclusion Criteria:

  • anorexia in starvation with 16 or under
  • substance abuse disorder
  • psychosis
  • needing interpreter
  • intellectual disability
  • and for those who do the neurofeedback, severe claustrophobia, pregnancy and braces
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
60 participants (estimated)

Study arms

  • Experimental
    real-time functional magnetic resonance imaging neurofeedback and real-time biofeedback

    Three sessions of real-time functional magnetic resonance imaging neurofeedback (rt-fMRI-NF) or real-time biofeedback training where participants will receive direct visual feedback from the blood oxygenation level dependent (BOLD) imaging signaling from the salience network in rt-fMRI-NF or visual feeback from a physiological signal in the real-time biofeedback (active condition)

    Other: Real-time functional magnetic resonance imaging Neurofeedback and Real-time Biofeedback

  • Sham comparator
    Sham feedback

    Three session where participants will be given a yoked sham feedback as control condition.

    Other: Sham functional magnetic resonance imaging neurofeedback and sham biofeedback

Interventions

  • OtherReal-time functional magnetic resonance imaging Neurofeedback and Real-time Biofeedback

    Participants will take part in three runs of real-time functional magnetic resonance imaging feedback (rt-fMRI-NF) training with 4-8 days apart, which will be conducted at the Center for Medical Image Science and Visualization (CMIV) at the university hospital in Linköping. Participants who receive biofeedback will take part in three runs of biofeedback with 4-8 days apart conducted in the lab at the Center for Social and Affective Neuroscience (CSAN) at Linköping university. Participants will be given instructions and basic psychoeducation of brain function and the rational for down-regulating the area of the brain that drives emotion, as well as the physiological reaction that is triggered in response to emotional stimuli. The emotional stimuli are emotional pictures from the International Affective Picture System (IAPS) and the Open Affective Standardized Image Set (OASIS).

  • OtherSham functional magnetic resonance imaging neurofeedback and sham biofeedback

    Participants will take part in three runs of sham neurofeedback with 4-8 days apart, which will be conducted at the Center for Medical Image Science and Visualization (CMIV) at the university hospital in Linköping. Participants who receive sham biofeedback will take part in three runs of sham biofeedback with 4-8 days apart conducted in the lab at the Center for Social and Affective Neuroscience (CSAN) at Linköping university. Participants will be given instructions and basic psychoeducation of brain function and the rational for down-regulating the area of the brain that drives emotion, as well as the physiological reaction that is triggered in response to emotional stimuli. The emotional stimuli are emotional pictures from the International Affective Picture System (IAPS) and the Open Affective Standardized Image Set (OASIS).

06

What researchers measure

Primary outcomes

  1. Emotional reactivity

    Changes of emotional reactivity is measured with facial electromyography (facialEMG). High zygomatic and corrugator response indicate higher emotional reactivity.

    Time frame: Change from baseline up to 5 weeks

  2. Hemodynamic activity

    Changes of the blood oxygenation level dependent (BOLD) response during real-time fMRI-neurofeedback for the neurofeedback training. The aim is to down-regulate the hemodynamic activity in the salience network.

    Time frame: Change from baseline at up to 4 weeks

  3. Psychophysiological response

    Changes of psychophysiological response during the real-time biofeedback training. The aim is to decrease the emotional reactivity and psychophysiological response.

    Time frame: Change from baseline at up to 4 weeks

Secondary outcomes

  1. Nonsuicidal self-injury

    Changes of self-reported frequency in nonsuicidal self-injury (NSSI). NSSI frequency is measured using the short 9-item version of the Deliberate Self-Harm Inventory (DSHI). Open ended questions are used for frequency with a range from 0 to several hundreds, depending on participants answers. Higher scores indicate more NSSI frequency and worse outcome.

    Time frame: Change from baseline at up to 5 weeks, and at additional 6 weeks and 3 month follow-up

  2. Difficulties with emotion regulation

    Changes of self-reported difficulties with emotion regulation. Difficulties with emotion regulation is measured using the 16-item version of the Difficulties with Emotion Regulation Scale (DERS-16). Scores range from 16 to 80 where higher scores indicate more difficulties with emotion regulation.

    Time frame: Change from baseline at up to 5 weeks, and at additional 6 weeks and 3 month follow-up

  3. Emotional reactivity

    Changes of self-reported emotional reactivity. Emotional reactivity is measured with the Emotion Reactivity Scale (ERS). Total scores range from 0 to 84 and a higher score indicates a worse outcome.

    Time frame: Change from baseline at up to 5 weeks, and at additional 6 weeks and 3 month follow-up

  4. Emotional awareness

    Changes of self-reported emotional awareness. Emotional awareness is measured with Toronto Alexithymia Scale, 20 items (TAS-20). TAS-20 total score ranges from 20 to 100 and higher scores indicate worse outcome.

    Time frame: Change from baseline at up to 5 weeks, and at additional 6 weeks and 3 month follow-up

  5. Psychiatric symptoms

    Changes of self-reported psychiatric symptoms. Psychiatric symptomatology is measured with the Trauma Symptom Checklist for Children (TSCC) with subscales: depression, anxiety, dissociation, posttraumatic stress, anger and sexual preoccupation. The total scale ranges from 0 to 162 and higher scores indicate worse outcome.

    Time frame: Change from baseline at up to 5 weeks, and at additional 6 weeks and 3 month follow-up

  6. Self-criticism

    Changes of self-reported levels of self-criticism. Self-criticism is measured with the Self-Rating Scale (SRS). Scores range from 8 to 56, and higher scores indicate higher levels of self-criticism.

    Time frame: Change from baseline at up to 5 weeks, and at additional 6 weeks and 3 month follow-up

  7. Functions of nonsuicidal self-injury

    Changes of self-reported levels of nonsuicidal self-injury (NSSI) functions. NSSI functions is measured using Clinical Assessment of Nonsuicidal Self-Injury Disorder Index (CANDI). Functions are rated as percentages and scores range from 0 to 100% where higher scores indicate higher usage of a specific NSSI function.

    Time frame: Change from baseline at up to 5 weeks, and at additional 6 weeks and 3 month follow-up

07

Study locations

1 of 1 sites recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 16, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05656001
Lead sponsor
Region Östergötland
Responsible party
Maria Zetterqvist (Principal investigator, Region Östergötland) — Principal investigator
First posted
Dec 19, 2022
Start date
Sep 10, 2021
Primary completion
Jun 2027 (estimated)
Completion
Sep 2027 (estimated)
Last update
Sep 16, 2026

Study contacts

Maria Zetterqvist, PhD
Contact
maria.zetterqvist@regionostergotland.se
+46 10-1034339
Maria Zetterqvist, PhD
principal investigator · Region Östergötland and Linköping university

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion